Safety and pharmacodynamics of dalazatide, a Kv1.3 channel...

PLoS ONE 2017 / 7 Vol. 12; Iss. 7

Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial

Tarcha, Eric J., Olsen, Chelsea M., Probst, Peter, Peckham, David, Muñoz-Elías, Ernesto J., Kruger, James G., Iadonato, Shawn P., Wiendl, Heinz
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0180762
Date:
July, 2017
File:
PDF, 4.97 MB
english, 2017
Conversion to is in progress
Conversion to is failed